ESTRELLA IMMUNOPHARMA, INC.: net income or loss
Net income or loss for ESTRELLA IMMUNOPHARMA, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ESTRELLA IMMUNOPHARMA, INC. financial histories
What this measure means
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
Exact concept: us-gaap:NetIncomeLoss. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-01-06 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -13,063,512 | USD | 2026-03-18 | 10-K · 0001213900-26-029357 |
| 2023-07-01 | 2024-06-30 | -7,311,723 | USD | 2024-09-27 | 10-K · 0001213900-24-082374 |
| 2022-07-01 | 2023-06-30 | -11,114,402 | USD | 2024-09-27 | 10-K · 0001213900-24-082374 |
| 2022-01-01 | 2022-12-31 | -996,104 | USD | 2023-03-14 | 10-K · 0001575872-23-000353 |
| 2021-01-06 | 2021-12-31 | -247,718 | USD | 2023-03-14 | 10-K · 0001575872-23-000353 |
Related financial histories
- ESTRELLA IMMUNOPHARMA, INC.: total assets
- ESTRELLA IMMUNOPHARMA, INC.: total liabilities
- ESTRELLA IMMUNOPHARMA, INC.: stockholders equity
- ESTRELLA IMMUNOPHARMA, INC.: cash and cash equivalents
- ESTRELLA IMMUNOPHARMA, INC.: operating cash flow
- ESTRELLA IMMUNOPHARMA, INC.: financing cash flow
- ESTRELLA IMMUNOPHARMA, INC.: investing cash flow
- ESTRELLA IMMUNOPHARMA, INC.: retained earnings or deficit
- ESTRELLA IMMUNOPHARMA, INC.: basic weighted-average shares
- ESTRELLA IMMUNOPHARMA, INC.: diluted weighted-average shares
- ESTRELLA IMMUNOPHARMA, INC.: basic earnings per share
- ESTRELLA IMMUNOPHARMA, INC.: diluted earnings per share
- ESTRELLA IMMUNOPHARMA, INC.: income tax expense or benefit
- ESTRELLA IMMUNOPHARMA, INC.: share-based compensation expense
- ESTRELLA IMMUNOPHARMA, INC.: operating income or loss
- ESTRELLA IMMUNOPHARMA, INC.: current assets
- ESTRELLA IMMUNOPHARMA, INC.: current liabilities
- ESTRELLA IMMUNOPHARMA, INC.: operating expenses
- ESTRELLA IMMUNOPHARMA, INC.: research and development expense
Inspect the source
- Entity
- ESTRELLA IMMUNOPHARMA, INC. / CIK 0001844417
- Captured
- 2026-09-21T17:30:17.565Z
- SEC response SHA-256
0d6a09fe04855c71f90123cc6e30e8f7f9e3767836b4d533de9056afed987397
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001844417.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))